DNA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ginkgo Bioworks Holdings Inc

Watchlist Manager

Watchlist

Price: 8.03 USD 13.74% Market Closed

Market Cap: $500.4m

	Ginkgo Bioworks Holdings Inc NYSE:DNA	US
	NetApp Inc NASDAQ:NTAP	US
	Endesa SA F:ENAA	ES
	Lineage Inc NASDAQ:LINE	US
	ESCO Technologies Inc NYSE:ESE	US
	Compass Group PLC LSE:CPG	UK
	Schneider Electric SE PAR:SU	FR
	Six Flags Entertainment Corp F:6FE0	US
H	Halma PLC F:H11	UK
	Elis SA PAR:ELIS	FR

Profitability Summary

Ginkgo Bioworks Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

71% > 78%

Negative Operating Margin

-258%

Negative 3Y Average Operating Margin

-212%

Operating Margin is Increasing

-370% > -258%

Negative Net Margin

-260%

Negative 3Y Average Net Margin

-270%

Net Margin is Increasing

-376% > -260%

Negative Free Cash Flow Margin

-156%

Negative 3Y Average Free Cash Flow Margin

-142%

Declining Free Cash Flow Margin

-113% > -156%

Negative ROE

-56%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-53%

ROIC is Increasing

-135% > -40%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.